Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus (HBV) DNA polymerase, also known as reverse transcriptase (RT), is a multifunctional viral enzyme essential for HBV replication. It catalyzes the conversion of pre-genomic RNA (pgRNA) into relaxed circular DNA (rcDNA) within the viral capsid, a process central to the HBV life cycle. It is a key target for antiviral therapies.
Nucleos(t)ide analogs inhibit HBV DNA polymerase activity, disrupting viral replication.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus DNA Polymerase (Reverse Transcriptase) (None).